AMITIZA for treatment of chronic constipation obtainable in Japan now Sucampo Pharmaceuticals.

AMITIZA for treatment of chronic constipation obtainable in Japan now Sucampo Pharmaceuticals, Inc buy silagra . AMITIZA was authorized by the Ministry of Health, Labor and Welfare in Japan in June. We are pleased to bring AMITIZA's connection with six years and more than 6 million prescriptions in the United States to the Japanese market, to benefit the healthcare patients and providers who require it, says Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo's Chairman and Chief Executive Officer. Chronic constipation is a medical condition affecting several million people in Japan and is one of the most common digestive condition issues. Healthcare providers will will have a prescription substitute for help regard this condition better and longer term, compared to currently approved over-the-counter medications, says Akihiko Honda, General Supervisor, Abbott Japan.

AMA awards HMS contract for alternative party recovery activities Today announced that it turned out awarded a contract by the State of HMS Alabama Medicaid Company to provide various third party recovery activities, including data matches with commercial and government insurors, industrial and Medicare recoveries, real-time pharmacy price avoidance, subrogation, and credit balance audit services. This contract is definitely for a two-year term, with three additional one-calendar year renewal options.